NCT01643135View on ClinicalTrials.gov

Reduction Bleeding in Laminectomy With Double Doses of Tranexamic Acid

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Bleeding
Interventions
DRUG

tranexamic acid

Transamine acts as antifibrinolysis which looks alike 0.9% NaCl (placebo)

DRUG

0.9% NaCl

0.9% NaCL (NSS) is clear fluid which looks alike tranexamic acid

Trial Locations (1)

10700

Manee Raksakietisak, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT01643135 - Reduction Bleeding in Laminectomy With Double Doses of Tranexamic Acid | Biotech Hunter | Biotech Hunter